Clive Page

Clive Page

Chairman at EpiEndo Pharmaceuticals ehf

66 year
Health Technology
Commercial Services
Consumer Services

Profile

Clive P.
Page
is the founder of Verona Pharma Plc, which was founded in 2005.
He is currently the President & Chairman of EpiEndo Pharmaceuticals ehf, a Non-Executive Director of Babraham Bioscience Technologies Ltd., Brabraham Biotechnology Ltd., and Ananda Developments Plc, a Director of PrEP Biopharm Ltd., a Professor at King's College London, a Trustee of The Babraham Institute, and a Member of the British Pharmacological Society.
Dr. Page is a former Chairman of Stirling Wealth Group Ltd.
and a former Director of Helperby Therapeutics Group Ltd.
and Revolo Biotherapeutics Ltd.
He received a doctorate degree from the University of London in 1984.

Clive Page active positions

CompaniesPositionStart
Brabraham Biotechnology Ltd. Director/Board Member -
King's College London Corporate Officer/Principal -
Corporate Officer/Principal -
Director/Board Member -
Director/Board Member -
Chairman -
Director/Board Member 2016-08-08
Director/Board Member 2023-03-26
All active positions of Clive Page

Former positions of Clive Page

CompaniesPositionEnd
VERONA PHARMA PLC Founder 2014-11-30
░░░░░░░░ ░░░░░░░░░░░░ ░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░░░ ░░░░░ ░░░ ░░░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░░░░░░░░░░░░ ░░░░ ░░░░░░░░ -
See the detail of Clive Page's experience

Training of Clive Page

University of London Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Clive Page's experience

Connections

100 +

1st degree connections

13

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies2
VERONA PHARMA PLC

Health Technology

World

Finance

Private companies9

Health Technology

Commercial Services

Commercial Services

Miscellaneous

Commercial Services

Brabraham Biotechnology Ltd.

Health Technology

Health Technology

Health Technology

See company connections
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW